Literature DB >> 23906202

Model for hepatitis C virus transmissions.

Elamin H Elbasha1.   

Abstract

Hepatitis C virus (HCV) is a leading cause of chronic liver disease. This paper presents a deterministic model for HCV infection transmission and uses the model to assess the potential impact of antiviral therapy. The model is based on the susceptible-infective-removed-susceptible (SIRS) compartmental structure with chronic primary infection and possibility of reinfection. Important epidemiologic thresholds such as the basic and control reproduction numbers and a measure of treatment impact are derived. We find that if the control reproduction number is greater than unity, there is a locally unstable infection-free equilibrium and a unique, globally asymptotically stable endemic equilibrium. If the control reproduction number is less than unity, the infection-free equilibrium is globally asymptotically stable, and HCV will be eliminated. Numerical simulations suggest that, besides the parameters that determine the basic reproduction number, reinfection plays an important role in HCV transmissions and magnitude of the public health impact of antiviral therapy. Further, treatment regimens with better efficacy holds great promise for lowering the public health burden of HCV disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23906202     DOI: 10.3934/mbe.2013.10.1045

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  5 in total

1.  The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.

Authors:  David P Durham; Laura A Skrip; Robert Douglas Bruce; Silvia Vilarinho; Elamin H Elbasha; Alison P Galvani; Jeffrey P Townsend
Journal:  Clin Infect Dis       Date:  2015-11-30       Impact factor: 9.079

Review 2.  Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies.

Authors:  Ashley B Pitcher; Annick Borquez; Britt Skaathun; Natasha K Martin
Journal:  J Theor Biol       Date:  2018-11-16       Impact factor: 2.691

3.  Should we treat acute hepatitis C? A decision and cost-effectiveness analysis.

Authors:  Emily D Bethea; Qiushi Chen; Chin Hur; Raymond T Chung; Jagpreet Chhatwal
Journal:  Hepatology       Date:  2018-01-24       Impact factor: 17.425

Review 4.  Population Health and Cost-Effectiveness Implications of a "Treat All" Recommendation for HCV: A Review of the Model-Based Evidence.

Authors:  Lauren E Cipriano; Jeremy D Goldhaber-Fiebert
Journal:  MDM Policy Pract       Date:  2018-05-24

5.  Probing a Stochastic Epidemic Hepatitis C Virus Model with a Chronically Infected Treated Population.

Authors:  S P Rajasekar; M Pitchaimani; Quanxin Zhu
Journal:  Acta Math Sci       Date:  2022-07-25       Impact factor: 1.085

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.